by Dolly the Sheep | Apr 1, 2026 | Cancer, Drug Discovery, Immunology, Stem Cell
RESOURCES FROM KACTUS Article: CDCP1: A New Therapeutic Target for Malignant Tumors Natasha Slepak from KACTUS recently published a new article talking about CDCP1: A New Therapeutic Target for Malignant Tumors. CDCP1 (CUB Domain-Containing Protein 1) is a...
by Dolly the Sheep | Apr 1, 2026 | Drug Discovery, Immunology, in vivo Studies, Organoids, Stem Cell
ARTICLE BY BIO X CELL Translational Continuity: Why Drug Programs Fail Early Bio X Cell has recently published an article talking about why over 90% of drug candidates fail in clinical trials, often due to the inability of animal models to accurately predict human...
by Dolly the Sheep | Mar 30, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies, Organoids, Stem Cell
E-BOOK BY BIO X CELL Functional Antibodies: Principles for Translational Confidence Antibodies are among the most versatile tools in translational research, bridging immune defense and experimental discovery. The recent e-book published by Bio X Cell introduces the...
by Dolly the Sheep | Mar 30, 2026 | Drug Discovery, Immunology, in vivo Studies, Organoids, Stem Cell
ARTICLE BY BIO X CELL Tools for the Next Generation of Therapeutic Research As drug discovery shifts toward organoids, NAMs, and human-relevant systems, researchers need tools that deliver true biological fidelity, not artifacts. Reproducibility doesn’t start at...
by Dolly the Sheep | Mar 26, 2026 | Cancer, Disease Modelling, Immunology, Neurology, Organoids, Stem Cell, Virology
ARTICLE BY BIO X CELL Advancing Organoid Research: Current Insights, Challenges, and the Path Forward As organoid systems move from experimental models to core translational tools, researchers are gaining unprecedented insight into human biology. But increased...
